NCT00498875

Brief Summary

Primary Objectives:

  • Develop and pilot test an innovative intervention to determine its feasibility and acceptability to patients. Recruitment rate, patient satisfaction, attendance, questionnaire completion rates and the reliability and validity of the questionnaires will be assessed.
  • Conduct preliminary analyses on the efficacy of the intervention in improving patients' depression. Evaluate whether depression levels in patients receiving the intervention decreases, and whether the decrease is greater among those who complete more sessions.
  • Test the relationship between patients' depression levels and adherence to swallowing rehabilitation and to dental preventive maintenance regimens.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
185

participants targeted

Target at P50-P75 for all trials

Timeline
4mo left

Started Mar 2005

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress98%
Mar 2005Dec 2026

Study Start

First participant enrolled

March 15, 2005

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

July 6, 2007

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 10, 2007

Completed
19.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

March 9, 2026

Status Verified

March 1, 2026

Enrollment Period

21.8 years

First QC Date

July 6, 2007

Last Update Submit

March 5, 2026

Conditions

Keywords

Oropharyngeal CancerHead and Neck CancerDepressionQuestionnaireSurveyInterview

Outcome Measures

Primary Outcomes (1)

  • Recruitment rate, Patient satisfaction, Attendance, Questionnaire Completion Rates (questionnaire responses)

    5 Years

Study Arms (1)

Questionnaire + Depression Intervention

Behavioral: QuestionnaireBehavioral: Depression Intervention

Interventions

QuestionnaireBEHAVIORAL

Questionnaire regarding mood, coping with cancer, how closely you follow your treatment schedule, your thoughts, your demographic information (such as age and race), and your medical history. If the answers to your questionnaire indicate that you may be depressed, you will be offered the intervention portion of the study.

Also known as: Survey
Questionnaire + Depression Intervention

Sessions given over 7 weeks and each lasting 30-45 minutes, that use "cognitive-behavioral" techniques.

Questionnaire + Depression Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Study participants with stage I-IV Head and Neck Cancer.

You may qualify if:

  • Stage I-IV
  • At least 18 years of age
  • Speak and read English at a 7th grade level
  • Are oriented to time, person, and place
  • Have a Zubrod performance status of 0-3.
  • To be eligible for the pilot depression intervention patients must score 9 or above on the Patient Health Questionnaire (PHQ-9). Additionally, if a patient has an elevated PHQ score and does not meet the cutoff but expresses a desire to be in the intervention in order to relieve his or her depression, then the PI will contact the participant to further assess eligibility for the intervention. Patients who do not make the cut-off will still be included in the study's statistical analyses.

You may not qualify if:

  • \. Do not have other cancer diagnoses, excepting non-melanoma skin cancer.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Texas MD Anderson Cancer Center

Houston, Texas, 77030, United States

Location

Related Links

MeSH Terms

Conditions

Oropharyngeal NeoplasmsHead and Neck NeoplasmsDepression

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Pharyngeal NeoplasmsOtorhinolaryngologic NeoplasmsNeoplasms by SiteNeoplasmsPharyngeal DiseasesStomatognathic DiseasesOtorhinolaryngologic DiseasesBehavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Eileen H. Shinn, PhD

    M.D. Anderson Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 6, 2007

First Posted

July 10, 2007

Study Start

March 15, 2005

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

March 9, 2026

Record last verified: 2026-03

Locations